Pharma Sales Reps: Declined & Denied!
#Pharma Sales Reps: Declined & Denied!
Pharma Ups Its Investment in TV DTC Advertising
Ever since the U.S. allowed direct-to-consumer (DTC) advertising, a majority of the ad dollars were spent on TV, which made sense in past years...
How to Gloss Over Warnings in TV DTC Ads
Julieta Smith, group strategy director, McCann Humancare -- part of the same healthcare agency that won a Lions Health 2014 GOLD award for Fictional...
Operation: Frog – A Forerunner in the Genre of Gamification
▶ Review of Commodore 64 Version of Operation Frog. Back to the Gamification Future!
Meet Bayer’s Grants4Apps Team!
http://realpharmaguy.tumblr.com/post/115412913052/via-https-vine-co-v-ol9edxi9rqe
Bayer’s Grants4Apps: An accelerator run by a pharma company
Off-Label Uses Promoted in DTC Ads for Diabetes Drugs
Print and TV DTC ad for Farxiga
(click on image for an enlarged view)
Public Citizen, a consumer advocacy group with more than 350,000 members...
23andMe Appoints “e-Patient Davide” to the Newly Created Position of Chief Patient Officer
I just received the following press release via email.
23andMe Appoints "e-Patient Davide" to the Newly Created Position of Chief Patient Officer
Appointment is a First...
DTC Ad Spending Rises From the Grave: Pfizer Leads the Ghoulish Pack
This article presents the data and discusses Pfizer's leading role in the DTC ad resurgence, especially in regard to TV advertising, which accounts for almost 70% of all DTC advertising dollars.
The Debut of the Chief Patient Officer: Is It Just a Passing Fad or...
This article summarizes the roles of Chief Patient Officers in bringing the patient perspective into their company's work. Sanofi is used as a case study.
Pharma Marketing News Vol. 14, No. 3: April 2015
Welcome to Vol. 14, Issue No. 3 (APRIL 2015) of Pharma Marketing News. Patient centricity, direct-to-consumer advertising, and key opinion leaders are the focus of this issue. All are related in the sense that each area has seen major changes & shifts in thinking with more to come.













